Ronald Muhlenkamp - Muhlenkamp & Co Options Holdings (Q3 2016)
As of Sep 30, 2016, the Muhlenkamp & Co portfolio disclosed options positions in its latest SEC 13F filing reported on May 06, 2026. These filings include call and put options tied to underlying equity holdings, providing a deeper look at the fund's use of derivatives for exposure and hedging.
The reported options activity included 6 call contracts and 0 put contracts across companies such as Biogen Inc. (BIIB), Cisco Systems, Inc. (CSCO), Gilead Sciences, Inc. (GILD). Options positions can signal strategies around hedging risk, enhancing leverage, or adjusting portfolio exposure during market shifts.
Options Positions
Showing 6 of 6 positions.
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q3 2016 | BIIB | Biogen Inc. | CALL | 3,000 | $939.00 |
| Q3 2016 | CSCO | Cisco Systems, Inc. | CALL | 19,000 | $602.00 |
| Q3 2016 | GILD | Gilead Sciences, Inc. | CALL | 7,500 | $593.00 |
| Q3 2016 | BAC | Bank of America Corporation | CALL | 30,000 | $470.00 |
| Q3 2016 | PHM | PulteGroup, Inc. | CALL | 13,000 | $261.00 |
| Q3 2016 | GM | General Motors Company | CALL | 6,400 | $203.00 |
Note: Notional value represents the total exposure of the options position.